+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anti-malarial Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report

  • 255 Pages
  • December 2023
  • Region: Global
  • Infinium Global Research
  • ID: 5542979
Description Jump to:
The report on the global anti-malarial drugs market provides qualitative and quantitative analysis for the period from 2021-2030. The global anti-malarial drugs market was valued at USD 947.67 million in 2022 and is expected to reach USD 1.36 billion in 2030, with a CAGR of 4.70% during the forecast period 2023-2030. The study on anti-malarial drugs market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.

The report on anti-malarial drugs market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global anti-malarial drugs market over the period of 2021-2030. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global anti-malarial drugs market over the period of 2021-2030. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • The high prevalence of malaria in endemic regions drives demand for anti-malarial drugs.
  • Increasing global awareness of the deadly impact of malaria drives the anti-malarial drug market.

2) Restraints

  • High prices of anti-malarial drugs make them unaffordable for many individuals which can hamper the market.

3) Opportunities

  • Advancements in drug development and the potential for novel, more effective anti-malarial treatments create lucrative opportunity for the market.

Research Methodology

A) Primary Research

The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global anti-malarial drugs market is segmented on the basis of drug class, route of administration, and distribution channel.

The Global Anti-malarial Drugs Market by Drug Class

  • Quinine
  • Chloroquine
  • Proguanil
  • Mefloquine
  • Others

The Global Anti-malarial Drugs Market by Route of Administration

  • Oral
  • Injectable

The Global Anti-malarial Drugs Market by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • E-commerce
  • Others

Company Profiles

The companies covered in the report include
  • Pfizer Inc.
  • weefselpharma.com.
  • Sun Pharmaceutical Industries Ltd.
  • Alvizia Health Care
  • Actiza Pharmaceutical Private Limited
  • Novartis AG
  • GSK plc.
  • Bayer AG
  • Ipca Laboratories Ltd.
  • Merck & Co., Inc.

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the anti-malarial drugs market.
2. Complete coverage of all the segments in the anti-malarial drugs market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global anti-malarial drugs market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Anti-malarial Drugs Market Highlights
2.2. Anti-malarial Drugs Market Projection
2.3. Anti-malarial Drugs Market Regional Highlights
Chapter 3. Global Anti-malarial Drugs Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Drug Class
3.4.2. Growth Matrix Analysis by Route Of Administration
3.4.3. Growth Matrix Analysis by Distribution Channel
3.4.4. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Anti-malarial Drugs Market
Chapter 4. Anti-malarial Drugs Market Macro Indicator Analysis
Chapter 5. Company Profiles and Competitive Landscape
5.1. Competitive Landscape in the Global Anti-malarial Drugs Market
5.2. Companies Profiles
5.2.1. Pfizer Inc.
5.2.2. weefselpharma.com.
5.2.3. Sun Pharmaceutical Industries Ltd.
5.2.4. Alvizia Health Care
5.2.5. Actiza Pharmaceutical Private Limited
5.2.6. Novartis AG
5.2.7. GSK plc.
5.2.8. Bayer AG
5.2.9. Ipca Laboratories Ltd.
5.2.10. Merck & Co., Inc.
Chapter 6. Global Anti-malarial Drugs Market by Drug Class
6.1. Quinine
6.2. Chloroquine
6.3. Proguanil
6.4. Mefloquine
6.5. Others
Chapter 7. Global Anti-malarial Drugs Market by Route Of Administration
7.1. Oral
7.2. Injectable
Chapter 8. Global Anti-malarial Drugs Market by Distribution Channel
8.1. Hospital Pharmacy
8.2. Retail Pharmacy
8.3. E-commerce
8.4. Others
Chapter 9. Global Anti-malarial Drugs Market by Region 2023-2030
9.1. North America
9.1.1. North America Anti-malarial Drugs Market by Drug Class
9.1.2. North America Anti-malarial Drugs Market by Route Of Administration
9.1.3. North America Anti-malarial Drugs Market by Distribution Channel
9.1.4. North America Anti-malarial Drugs Market by Country
9.1.4.1. The U.S. Anti-malarial Drugs Market
9.1.4.1.1. The U.S. Anti-malarial Drugs Market by Drug Class
9.1.4.1.2. The U.S. Anti-malarial Drugs Market by Route Of Administration
9.1.4.1.3. The U.S. Anti-malarial Drugs Market by Distribution Channel
9.1.4.2. Canada Anti-malarial Drugs Market
9.1.4.2.1. Canada Anti-malarial Drugs Market by Drug Class
9.1.4.2.2. Canada Anti-malarial Drugs Market by Route Of Administration
9.1.4.2.3. Canada Anti-malarial Drugs Market by Distribution Channel
9.1.4.3. Mexico Anti-malarial Drugs Market
9.1.4.3.1. Mexico Anti-malarial Drugs Market by Drug Class
9.1.4.3.2. Mexico Anti-malarial Drugs Market by Route Of Administration
9.1.4.3.3. Mexico Anti-malarial Drugs Market by Distribution Channel
9.2. Europe
9.2.1. Europe Anti-malarial Drugs Market by Drug Class
9.2.2. Europe Anti-malarial Drugs Market by Route Of Administration
9.2.3. Europe Anti-malarial Drugs Market by Distribution Channel
9.2.4. Europe Anti-malarial Drugs Market by Country
9.2.4.1. Germany Anti-malarial Drugs Market
9.2.4.1.1. Germany Anti-malarial Drugs Market by Drug Class
9.2.4.1.2. Germany Anti-malarial Drugs Market by Route Of Administration
9.2.4.1.3. Germany Anti-malarial Drugs Market by Distribution Channel
9.2.4.2. United Kingdom Anti-malarial Drugs Market
9.2.4.2.1. United Kingdom Anti-malarial Drugs Market by Drug Class
9.2.4.2.2. United Kingdom Anti-malarial Drugs Market by Route Of Administration
9.2.4.2.3. United Kingdom Anti-malarial Drugs Market by Distribution Channel
9.2.4.3. France Anti-malarial Drugs Market
9.2.4.3.1. France Anti-malarial Drugs Market by Drug Class
9.2.4.3.2. France Anti-malarial Drugs Market by Route Of Administration
9.2.4.3.3. France Anti-malarial Drugs Market by Distribution Channel
9.2.4.4. Italy Anti-malarial Drugs Market
9.2.4.4.1. Italy Anti-malarial Drugs Market by Drug Class
9.2.4.4.2. Italy Anti-malarial Drugs Market by Route Of Administration
9.2.4.4.3. Italy Anti-malarial Drugs Market by Distribution Channel
9.2.4.5. Rest of Europe Anti-malarial Drugs Market
9.2.4.5.1. Rest of Europe Anti-malarial Drugs Market by Drug Class
9.2.4.5.2. Rest of Europe Anti-malarial Drugs Market by Route Of Administration
9.2.4.5.3. Rest of Europe Anti-malarial Drugs Market by Distribution Channel
9.3. Asia Pacific
9.3.1. Asia Pacific Anti-malarial Drugs Market by Drug Class
9.3.2. Asia Pacific Anti-malarial Drugs Market by Route Of Administration
9.3.3. Asia Pacific Anti-malarial Drugs Market by Distribution Channel
9.3.4. Asia Pacific Anti-malarial Drugs Market by Country
9.3.4.1. China Anti-malarial Drugs Market
9.3.4.1.1. China Anti-malarial Drugs Market by Drug Class
9.3.4.1.2. China Anti-malarial Drugs Market by Route Of Administration
9.3.4.1.3. China Anti-malarial Drugs Market by Distribution Channel
9.3.4.2. Japan Anti-malarial Drugs Market
9.3.4.2.1. Japan Anti-malarial Drugs Market by Drug Class
9.3.4.2.2. Japan Anti-malarial Drugs Market by Route Of Administration
9.3.4.2.3. Japan Anti-malarial Drugs Market by Distribution Channel
9.3.4.3. India Anti-malarial Drugs Market
9.3.4.3.1. India Anti-malarial Drugs Market by Drug Class
9.3.4.3.2. India Anti-malarial Drugs Market by Route Of Administration
9.3.4.3.3. India Anti-malarial Drugs Market by Distribution Channel
9.3.4.4. South Korea Anti-malarial Drugs Market
9.3.4.4.1. South Korea Anti-malarial Drugs Market by Drug Class
9.3.4.4.2. South Korea Anti-malarial Drugs Market by Route Of Administration
9.3.4.4.3. South Korea Anti-malarial Drugs Market by Distribution Channel
9.3.4.5. Australia Anti-malarial Drugs Market
9.3.4.5.1. Australia Anti-malarial Drugs Market by Drug Class
9.3.4.5.2. Australia Anti-malarial Drugs Market by Route Of Administration
9.3.4.5.3. Australia Anti-malarial Drugs Market by Distribution Channel
9.3.4.6. Rest of Asia-Pacific Anti-malarial Drugs Market
9.3.4.6.1. Rest of Asia-Pacific Anti-malarial Drugs Market by Drug Class
9.3.4.6.2. Rest of Asia-Pacific Anti-malarial Drugs Market by Route Of Administration
9.3.4.6.3. Rest of Asia-Pacific Anti-malarial Drugs Market by Distribution Channel
9.4. RoW
9.4.1. RoW Anti-malarial Drugs Market by Drug Class
9.4.2. RoW Anti-malarial Drugs Market by Route Of Administration
9.4.3. RoW Anti-malarial Drugs Market by Distribution Channel
9.4.4. RoW Anti-malarial Drugs Market by Sub-region
9.4.4.1. Latin America Anti-malarial Drugs Market
9.4.4.1.1. Latin America Anti-malarial Drugs Market by Drug Class
9.4.4.1.2. Latin America Anti-malarial Drugs Market by Route Of Administration
9.4.4.1.3. Latin America Anti-malarial Drugs Market by Distribution Channel
9.4.4.2. Middle East Anti-malarial Drugs Market
9.4.4.2.1. Middle East Anti-malarial Drugs Market by Drug Class
9.4.4.2.2. Middle East Anti-malarial Drugs Market by Route Of Administration
9.4.4.2.3. Middle East Anti-malarial Drugs Market by Distribution Channel
9.4.4.3. Africa Anti-malarial Drugs Market
9.4.4.3.1. Africa Anti-malarial Drugs Market by Drug Class
9.4.4.3.2. Africa Anti-malarial Drugs Market by Route Of Administration
9.4.4.3.3. Africa Anti-malarial Drugs Market by Distribution Channel

Companies Mentioned

  • Pfizer Inc.
  • weefselpharma.com.
  • Sun Pharmaceutical Industries Ltd.
  • Alvizia Health Care
  • Actiza Pharmaceutical Private Limited
  • Novartis AG
  • GSK plc.
  • Bayer AG
  • Ipca Laboratories Ltd.
  • Merck & Co., Inc.

Table Information

Report AttributeDetails
No. of Pages255
PublishedDecember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 947.67 Million
Forecasted Market Value ( USD ) by 2030 $ 1360 Million
Compound Annual Growth Rate4.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Anti-Malarial Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Anti-Malarial Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 102 Pages
  • Global
From
Systemic Lupus Erythematosus (SLE) Drugs Market by Drug Class (Antimalarials Drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Cytotoxic and Immunosuppressive Drugs, Biologics, and Others), Mode of Delivery (Intravenous, Subcutaneous, Oral), and Region 2024-2032 - Product Image

Systemic Lupus Erythematosus (SLE) Drugs Market by Drug Class (Antimalarials Drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Cytotoxic and Immunosuppressive Drugs, Biologics, and Others), Mode of Delivery (Intravenous, Subcutaneous, Oral), and Region 2024-2032

  • Report
  • 142 Pages
  • Global
From
Antimalarial Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Drug Class Coverage, Route of Administration Coverage, Distribution Channel Coverage, Geographic Coverage and Leading Companies) - Product Image

Antimalarial Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Drug Class Coverage, Route of Administration Coverage, Distribution Channel Coverage, Geographic Coverage and Leading Companies)

  • Report
  • 185 Pages
  • Global
Antimalarial Medication Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Antimalarial Medication Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 104 Pages
  • Global
From
Germany Anti-malarial Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Image

Germany Anti-malarial Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • 80 Pages
  • Germany
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.